Aktiesnakken — Juli 2010
-
Vi vil skåle for de dumme analytikere og deres fattige kunder for de trænger til det, da hverken kan læse indenad eller tabellen udenad.
-
I skal også huske på at bare en lille ændring i sandsynligheden for at arzerra i RA eller ms, forøger analytikernes værdi betydeligt
-
hvad var det Peter AAbo opskrev med
-
jeg tror det var 6 -8 kr per aktie
-
så genmab kan vel godt som mægler sige gå helt op til 66
-
men jeg er jo ikke god til den kortsigtede
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind